Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents.
about
Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policiesPharmaceutical policies: effects of reference pricing, other pricing, and purchasing policiesFirst-line first? Trends in thiazide prescribing for hypertensive seniorsChanges in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gapPotential Savings from an Evidence-Based Consumer-Oriented Public Education Campaign on Prescription DrugsRational prescribing in primary care (RaPP): economic evaluation of an intervention to improve professional practice.Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?Reference drug programs: effectiveness and policy implications.The impact of cost sharing on antidepressant use among older adults in British Columbia.Impact of drug cost sharing on service use and adverse clinical outcomes in elderly receiving antidepressants.Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarctionEffects of prescription coinsurance and income-based deductibles on net health plan spending for older users of inhaled medications.The potential economic impact of restricted access to angiotensin-receptor blockersDrug insurance utilization management policies and "reference pricing": an illustrated commentary on the article by Vittorio Maio and colleagues.What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbiaThe effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbia.Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study.Does knowledge of medication prices predict physicians' support for cost effective prescribing policies.Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias.
P2860
Q24193097-3809DF13-C640-4DCB-B05B-A211B5BE5AA6Q24246148-2F1ABA0C-1948-4A30-8E79-8E567CFFD3ADQ24792251-1BFFA396-BB33-4534-85CA-8E44F57174F5Q28476575-570BB81B-9BEE-4AFA-8C57-DBF8F3262EB7Q29393270-29DD13A2-8DD6-413B-9158-ABE3092742C1Q33245267-16C99130-E7E9-41B0-8E05-3D98E5DAC234Q33664087-32CF558B-0068-4A5E-B2F7-52F964A541CCQ33908085-28950FDD-A083-46A7-8AF2-27C4F54389D8Q33908092-86BB3100-F88A-4296-8733-A625B2649DEBQ33942027-7D97B3F3-3D57-4EF0-844B-0BEE18EAA422Q34001855-48DBBF58-7962-4672-A065-FB1978257E2CQ34001878-2582856C-6424-449A-A6A9-8B6F6DCEB6B8Q34590001-0253963E-8965-4A40-AD2B-3F6F8ED32F2CQ36078789-F3747040-8422-4DF4-9CAC-54587376BA7AQ36699426-75E52D7C-1D1D-4C38-98CF-9D1EC50C6B5EQ37103226-41E9DC8A-5897-48E4-9B53-65207AF5CB35Q37420464-33745985-E73E-4E02-93F0-1B7AF1082755Q41654265-28F8FCAE-CECD-4CF3-AF96-832E590AA791Q42612841-FF65BCD3-5127-4215-B7D3-20EC993FA4B8Q53086583-2DE4FF54-5AB7-4A52-8624-50DA7085FE24
P2860
Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Net health plan savings from r ...... ly British Columbia residents.
@en
Net health plan savings from r ...... ly British Columbia residents.
@nl
type
label
Net health plan savings from r ...... ly British Columbia residents.
@en
Net health plan savings from r ...... ly British Columbia residents.
@nl
prefLabel
Net health plan savings from r ...... ly British Columbia residents.
@en
Net health plan savings from r ...... ly British Columbia residents.
@nl
P2093
P1433
P1476
Net health plan savings from r ...... ly British Columbia residents.
@en
P2093
Malcolm Maclure
Paul Grootendorst
Sebastian Schneeweiss
Stephen B Soumerai
P304
P356
10.1097/01.MLR.0000129497.10930.A2
P577
2004-07-01T00:00:00Z